Enfusion Inc
NYSE:ENFN
Intrinsic Value
Enfusion, Inc. engages in the development of cloud-native multi-tenant software for alternative and institutional investment managers. [ Read More ]
The intrinsic value of one ENFN stock under the Base Case scenario is 7.04 USD. Compared to the current market price of 9.25 USD, Enfusion Inc is Overvalued by 24%.
Valuation Backtest
Enfusion Inc
Run backtest to discover the historical profit from buying and selling ENFN stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Enfusion Reports Strong Q4 Growth and Client Expansion
2023-Q4 Earnings Call
Enfusion, in Q4 2023, showcased significant growth and predictability in its economic profile, with a 15% increase in revenue to $46.5 million and adjusted EBITDA hitting $9.8 million, marking a 21% margin and a 436-basis point year-over-year expansion. For the full year, revenue rose to $174.5 million, up 16%, and adjusted EBITDA improved by approximately 500 basis points to 18%. The quarter brought 45 new client additions, lifting the total count to 865 and average contract value (ACV) to $219,000, records for Enfusion. Key wins included the Utah Retirement Systems and Mariner Investment Group in the Americas, with regional revenues growing 15% year-over-year, while European revenues surged 24% with the onboardings of an asset manager in Belgium and a large Swedish family office. In APAC, a 7% revenue growth stemmed from a significant client conversion in South Korea, asserting Enfusion's market presence amid geopolitical challenges.
Balance Sheet Decomposition
Enfusion Inc
Current Assets | 69.9m |
Cash & Short-Term Investments | 35.6m |
Receivables | 28.1m |
Other Current Assets | 6.2m |
Non-Current Assets | 39.1m |
PP&E | 32.6m |
Other Non-Current Assets | 6.5m |
Current Liabilities | 20.3m |
Accounts Payable | 2.2m |
Accrued Liabilities | 18.1m |
Non-Current Liabilities | 35m |
Other Non-Current Liabilities | 35m |
Earnings Waterfall
Enfusion Inc
Revenue
|
174.5m
USD
|
Cost of Revenue
|
-57.6m
USD
|
Gross Profit
|
116.9m
USD
|
Operating Expenses
|
-104.9m
USD
|
Operating Income
|
11.9m
USD
|
Other Expenses
|
-5.6m
USD
|
Net Income
|
6.3m
USD
|
Free Cash Flow Analysis
Enfusion Inc
What is Free Cash Flow?
ENFN Profitability Score
Profitability Due Diligence
Enfusion Inc's profitability score is 35/100. The higher the profitability score, the more profitable the company is.
Score
Enfusion Inc's profitability score is 35/100. The higher the profitability score, the more profitable the company is.
ENFN Solvency Score
Solvency Due Diligence
Enfusion Inc's solvency score is 74/100. The higher the solvency score, the more solvent the company is.
Score
Enfusion Inc's solvency score is 74/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ENFN Price Targets Summary
Enfusion Inc
According to Wall Street analysts, the average 1-year price target for ENFN is 9.99 USD with a low forecast of 8.08 USD and a high forecast of 12.6 USD.
Ownership
ENFN Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
ENFN Price
Enfusion Inc
Average Annual Return | -20.43% |
Standard Deviation of Annual Returns | 39.87% |
Max Drawdown | -67% |
Market Capitalization | 831.3m USD |
Shares Outstanding | 89 871 104 |
Percentage of Shares Shorted | 3.6% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Enfusion, Inc. engages in the development of cloud-native multi-tenant software for alternative and institutional investment managers. The company is headquartered in Chicago, Illinois. The company went IPO on 2021-10-21. The products and services that comprise its solution are designed to enable investment managers to take investment decisions in real time. The Company’s solution, comprised of mission critical systems integrated with a suite of technology-powered, managed services, serves the full investment lifecycle, drives insights into and control over the business activities of the investment manager and investment operations. Its solution’s end-to-end functionality includes Portfolio Management System (PMS), Order and Execution Management System (OEMS), Accounting/General Ledger System and Enfusion Analytics System. PMS able to comprehensively construct and re-balance investment portfolios, this system generates a real-time investment book of record. PMS module offers portfolio managers, traders, compliance teams and analysts the ability to electronically communicate trade orders.
Contact
IPO
Employees
Officers
The intrinsic value of one ENFN stock under the Base Case scenario is 7.04 USD.
Compared to the current market price of 9.25 USD, Enfusion Inc is Overvalued by 24%.